Natalia Novac

Natalia Novac is a distinguished business developer with over a decade of experience working in the pharmaceutical industry. She is renowned for her academic excellence, with a solid background in oncology, endocrinology, and immunology. Her impressive achievements include successfully scouting and evaluating external opportunities for Eli Lilly, globally mobilizing and managing 15,000 employees and launching an immune-oncology asset with peak sales estimated to be $4-6 billion for Merck-Pfizer. She is passionate about extending patient's lives by regularly providing external innovation consultancy to a number of late-stage development programs. She believes in life-long learning and has participated in several training and certification programs to improve her skills.